From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota
From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota
复制标题
DOI：
10.2174/1386207317666140109122033
复制
发表时间：
2014-03-01
影响因子：
1.8
通讯作者：
Wong, Henry L.
中科院分区：
文献类型：
--
作者：
Dosa, Peter I.;Georg, Gunda I.;Wong, Henry L.
The high-throughput screening core at the University of Minnesota is part of the Institute for Therapeutics Discovery and Development (ITDD), a comprehensive drug discovery and development center. The Institute provides scientific services to both academic and business communities and supports translational medicine via collaborations and contractual work. The ITDD is well-known for its broad range of screening capabilities and offers extensive medicinal chemistry expertise along with GMP scale-up and pre-clinical pharmacology support.
